FDA Webview
X

Free FDA Notices

Public Meeting on Breast Cancer Drug Development

12/19/2014

Federal Register Notice of public meeting: FDA will hold a public meeting 4/2 on patient-focused drug development for breast cancer. The meeting will be held 4/2/15, from 1 p.m. to 5 p.m. at the FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. Contact Pegah Mariani (240) 402-4513. To view this notice, click here.

LATEST NEWS